Your Compass for Pharma Success

VALIDATION POLICY

Validation Policy
Validation Policy

OBJECTIVE:

To define the Validations Policy for manufacturing products of consistent acceptable quality. The extent and degree of validation activity shall depend(s) on the nature and complexity of the equipment/product/process.

SCOPE:

This SOP is applicable for validation approach of new equipments / systems / instruments / processes at {Company Name} {Location}.

RESPONSIBILITY:

Validation Coordinator: Representatives of QA shall be responsible for preparation of validation protocols/reports, preparation of the schedule for conducting the validation studies and summarize and evaluation of validation data. QA in charge or his designee shall be responsible for Review of validation protocols and reports, Monitor the progress to ensure completion of validation as per schedule, to provide resource required for the validation studies within the given schedule.

Validation core committee: It comprises of Head QA, Head Engineering, Head Quality control & Head Production or their designees shall be responsible for Overall co-ordination of the validation programme, Review and Approval of validation protocols /reports, monitor applicable for c GMP aspects and identification of the training needs.

ACCOUNTABILITY:

QA Head shall be Accountable for implementation of SOP.

PROCEDURE:

The facility shall be validated in accordance with the systems, guidelines and procedures established by {Company Name}

All new equipments/systems/instruments/processes introduced in the manufacturing unit shall be validated prior to routine use.

Validation is required for the following, but not limited to:

  • If new equipment is introduced.
  • In the event of significant alterations or modifications to the processing equipment
  • If the composition of the product, the manufacturing procedure, or the batch size is changed.
  • If requested by regulatory authorities.

Validation protocols shall be prepared by the validation coordinator as per the contents listed out for each type of validation protocol as per the Validation Master Plan.

Validation protocols shall be checked by the task force leader and approved by the validation core committee.

The Validation Core Committee shall be comprised of senior representatives from the following departments/functions who will manage the validation program.

  • Quality Assurance
  • Production/QC (as applicable)
  • Engineering

The execution team shall be responsible for the execution of the approved protocols.

Click the link to download word file copy of this document:
https://pharmaguidehub.com/product/validation-policy/

New equipments shall be validated for Design Qualification, Installation Qualification, Operational Qualification and Performance Qualification (as applicable).

Re-validation of equipment, process and method shall be done as defined in the master validation plan.

Cleaning procedures shall be validated for the equipments and accessories used in the manufacturing process.

Analytical methods shall be validated for quantification of active ingredient, degradation substances, and for residual solvents in the product.

The report shall be prepared based on the results obtained.

The report shall be reviewed for approval by the validation core committee.

REFERENCES:

Not Applicable

ANNEXURES: 

Not Applicable

ENCLOSURES: SOP Training Record.

 DISTRIBUTION:

  • Controlled Copy No. 01  :    Head Quality Assurance
  • Controlled Copy No. 02  :    Head Production
  • Controlled Copy No. 03  :    Head Quality Control
  • Master Copy                    :    Quality Assurance Department

ABBREVIATIONS:

No.:Number
SOP:Standard Operating Procedure
QA:Quality Assurance
QC:Quality Control

REVISION HISTORY:

CHANGE HISTORY LOG
Revision No.Details of ChangesReason for ChangeEffective Date
00New SOPNot ApplicableTo Be Written Manual

Click the link to download word file copy of this document:
https://pharmaguidehub.com/product/validation-policy/

Share this article
Shareable URL
Prev Post

TREND ANALYSIS

Leave a Reply

Your email address will not be published. Required fields are marked *

Read next

Discover more from PharmaGuideHub

Subscribe now to keep reading and get access to the full archive.

Continue reading